[1]
“PRECISION PHARMACOTHERAPY IN TYPE 2 DIABETES MELLITUS: EVALUATING THE CARDIO-RENAL AND GLYCEMIC EFFICACY OF TARGET-SPECIFIC PATHWAY MODULATION”, Wor.Bul.Pub.Helt., vol. 56, pp. 82–84, Mar. 2026, Accessed: Aug. 03, 2026. Available: https://scholarexpress.net/index.php/wbph/article/view/5983